1. Future Prospective of Radiopharmaceuticals from Natural Compounds Using Iodine Radioisotopes as Theranostic Agents
   Wiwit Nurhidayah et al, 2022, Molecules CrossRef
2. Radiopharmaceutical study on Iodine-131-labelled hypericin in a canine model of hepatic RFA-induced coagulative necrosis
   Xiaojun Qi et al, 2015, La radiologia medica CrossRef
3. Predicting Clinical Efficacy of Vascular Disrupting Agents in Rodent Models of Primary and Secondary Liver Cancers: An Overview with Imaging-Histopathology Correlation
   Yewei Liu et al, 2020, Diagnostics CrossRef
4. Combretastatin A4‐phosphate and its potential in veterinary oncology: a review
   E. Abma et al, 2017, Veterinary and Comparative Oncology CrossRef
5. Avenues to molecular imaging of dying cells: Focus on cancer
   Anna A. Rybczynska et al, 2018, Medicinal Research Reviews CrossRef
6. Evans Blue Dye: A Revisit of Its Applications in Biomedicine
   Linpeng Yao et al, 2018, Contrast Media & Molecular Imaging CrossRef
7. Mechanisms Regulating Muscle Regeneration: Insights into the Interrelated and Time-Dependent Phases of Tissue Healing
   Laura Forcina et al, 2020, Cells CrossRef
8. Automated radiosynthesis of pharmaceutical grade [68Ga]Ga-NODAGA-Lys40-Exendin-4 and demonstration of its efficacy for use in patients
   Sreeja Raj Menon et al, 2024, Journal of Radioanalytical and Nuclear Chemistry CrossRef
9. An overview of translational (radio)pharmaceutical research related to certain oncological and non-oncological applications
   Marlein Miranda Cona, 2013, World Journal of Methodology CrossRef
10. 131I-Evans blue: evaluation of necrosis targeting property and preliminary assessment of the mechanism in animal models
    Qiaomei Jin et al, 2018, Acta Pharmaceutica Sinica B CrossRef
11. Biodistribution and tolerance of intravenous iodine‐131‐labelled hypericin in healthy dogs
    E. Abma et al, 2018, Veterinary and Comparative Oncology CrossRef